Recurrent Intravascular Large B-Cell Lymphoma
3 clinical trials · Condition
◉ Watch Recurrent Intravascular Large B-Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin's Lymphoma or Transformed Indolent B-cell Lymphoma (NCT05202782) | Northwestern University | 2022-03-21 |
Track Recurrent Intravascular Large B-Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.